Reykjavik, Iceland, 10 July 2008 — Actavis Group, the international generic pharmaceuticals company, today announced the launch of Bicalutamide tablets in the United Kingdom, Germany and France. Bicalutamide Actavis is the first generic version of the oncology drug to be made available in the three markets.
Bicalutamide, the generic version of AstraZeneca’s Casodex®, is used as [...]

Popularity: 7% [?]